Compare Jayamas Medica Industri Tbk. (OMED) vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF (XBIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Jayamas Medica Industri Tbk. vs Reksa Dana Indeks BNP Paribas IDX Growth30 ETF — how do they compare? Jayamas Medica Industri Tbk. trades at Rp214 (market cap 5.79T, 9.53M 24h volume), while Reksa Dana Indeks BNP Paribas IDX Growth30 ETF trades at Rp600 (market cap 120M). The key difference: Jayamas Medica Industri Tbk. is far larger — about 48250× Reksa Dana Indeks BNP Paribas IDX Growth30 ETF's market cap. Which is the better fit depends on your goals.
| OMED | XBIG | |
|---|---|---|
Market Cap | 5.79T | 120M |
Volume | 9.53M | — |
Lot | 95.3K | — |
Turnover | 2.05B | — |
Average Price | 215.03 | — |
Value | 2.05B | — |
Indicative Equilibrium Price | 214 | — |
Indicative Equilibrium Volume | 1.69K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
OMED
View details →XBIG
View details →About Jayamas Medica Industri Tbk.
PT Jayamas Medica Industri Tbk (the Company) was established based on Notarial deed No. 5 dated15 December 2000 of Devi Chrisnawati, S.H., Notary in Surabaya. The Company started its commercial operations since 2002.
Read more on OMED →
